Crown Bioscience Appoints John Gu as Chief Executive Officer

Contributed by: Business Wire

Tags

Research

Pharmaceutical

Data Management

Oncology

Technology

Artificial Intelligence

Clinical Trials

Science

Biotechnology

Alternative Medicine

FDA

Health

Other Science

research

More Like This

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening

JB Agnus, Chief Business Officer, KBI Biopharma, Inc. (Photo: Business Wire)

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer